Erratum: Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0)

Masashi Niwakawa, Katsuyoshi Hashine, Raizo Yamaguchi, Hirofumi Fujii, Yasuo Hamamoto, Koichi Fukino, Takahiko Tanigawa, Yoshiteru Sumiyoshi

研究成果: Comment/debate

元の言語English
ページ(範囲)1274-1275
ページ数2
ジャーナルInvestigational new drugs
30
発行部数3
DOI
出版物ステータスPublished - 2012 6 1
外部発表Yes

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)

これを引用